A peer-reviewed analysis of data in the Vaccine Adverse Event Reporting System found nearly 200 safety signals associated with RSV vaccines currently marketed to older adults and pregnant women. Researchers identified neurological disorders, blood disorders and serious complications for pregnant women and their infants, among many other issues. |